Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #92 on Myrexis, Inc. (MYRX)
sandtrap246
02/19/13 6:29 PM
#93 RE: RagingStocks #92
We expect to continue to see reduced research and development costs as a result of the decision to suspend further development activities for all preclinical and clinical programs and as a result of the transfer of all preclinical and clinical programs to third parties